Abstract
Spasticity is a frequent and complex sequel to spinal cord injury. The neurochemical basis for the origin of spasticity is largely unknown. Glycine is among the most abundant neurotransmitters in the spinal cord. However, the role of glycine and related compounds in spasticity have received little attention. An ischemic spinal cord injury was created in rabbits, by an intraaortic balloon occlusion technique, which produced lower limb spasticity. A catheter was inserted into the cisterna magna and the spinal cord was bathed with 100 μM solutions of glycine, strychnine,d-serine, β-alanine, MK-801, or artificial CSF for 4 hours at a rate of 10 μl/min. H-reflexes were monitored before and during infusion by stimulating the posterior tibial nerve and recording from the plantar surface of the foot. Glycine,d-serine, and MK-801 depressed the H wave, strychnine produced a heightened H wave, and β-alanine caused no significant changes. These results indicate that glycine and related compounds may influence spasticity.
Similar content being viewed by others
References
Ashby, P., and McCrea, D. A. 1987. Neurophysiology of spasticity. Pages 119–143,in Davidoff, R. A., (ed), Handbook of the Spinal Cord, Congenital Disorders and Trauma, Marce Dekker, Inc, New York.
Howell, D. A., Lees, A. J., and Toghill, P. J. 1979. Spinal internuncial neurones in progressive encephalomyelitis with rigidity. J. Neurol. Neurosurg. Psychiatry 42:773–785.
Kupers, H. G. J. M. 1973. Pages 38–68,in Desmedt, J. E., (ed), New developments in electromyography and clinical neurophysiology, Basel, Karger.
Hall, P. V., Smith, J. E., Lane, J., Mote, T., and Campbell, R. 1979. Glycine and experimental spinal spasticity. Neurology 29:262–267.
Larson, A. A. 1989. Intrathecal GABA, glycine, taurine or beta-alanine elicits dyskinetic movements in mice. Pharmacol. Biochem. Behav. 32:505–509.
Smith, J. E., Hall, P. V., Galvin, M. R., Jones, A. R. and Campbell, R. L. 1979. Effects of glycine administration on canine experimental spinal spasticity and the levels of glycine, glutamate, and aspartate in the lumbar spinal cord. Neurosurgery 4:152–156.
Yaksh, T. L. 1989. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: Effects of modulatory receptor systems and excitatory amino acid antagonists. Pain, 37:111–123.
Daly, E. C. and Aprison, M. H. 1983. Glycine. Pages 467–499,in Lajtha, A., (ed), Handbook of Neurochemistry, Plenum Press, New York.
Davidoff, R. A., Graham, L. T., Shank, R. P., Werman, R., and Aprison, M. H. 1967. Changes in amino acid concentrations associated with loss of spinal interneurons. J. Neurochem. 14:1025–1031.
Hammerstad, J. P., Murray, J. E., and Cutler, R. W. P. 1971. Efflux of amino acid neurotransmitters from rat spinal cord slices. II. Factors influencing the electrically induced efflux of [14C] glycine, and 3H-Gaba. Brain Res. 35:357–367.
Hopkin, J. and Neal, M. J. 1971. Effect of electrical stimulation and high potassium concentrations on the efflux of [14C] glycine from slices of spinal cord. Br. J. Pharmacol. 42:215–233.
Young, A. B. and Macdonald, R. L. 1987. Glycine as a spinal cord neurotransmitter. Pages 1–44,in Davidoff, R. A., (ed), Handbook of the Spinal Cord, Marcel Dekker Inc, New York.
Davidoff, R. A. 1985. Antispasticity drugs: Mechanism of action. Ann. Neurol. 17:107–116.
Herz, D. A., Looman, J. E., Tiberio, A., Ketterling, K., Kreitsch, R. K., Colwill, H. C., and Grin, O. D. 1990. The management of paralytic spasticity. Neurosurgery, 26:300–306.
Simpson, R. K. Jr., Robertson, C. S., and Goodman, J. C. 1993. Spinal epidural corticomotor evoked potentials as a predictor of outcome from ischemic myelopathy. Neurol. Res. 15:104–108.
Rymer, W. Z. and Powers, R. K. 1989. Pathophysiology of muscular hypertonia in spasticity. Pages 291–301,in Park, T. S., Phillips, L. H., and Peakock, W. J. (eds.), Management of spasticity interebral palsly and spinal cord injury, Neurosurgery: State of the Art Review, Hanley & Belfus, Inc., Philadelphia.
Shimoji, K., Shimizu, H., and Maruyama, Y. 1978. Origin of somatosensory evoked responses recorded from the cervical skin surface. J. Neurosurg. 48:980–984.
Ashby, P., Verrier, M., and Lightfoot, E. 1974. Segmental reflex pathways in spinal shock and spinal spasticity in man. J. Neurol. Neurosurg. Psychiat. 37:1352–1360.
Barolat-Romana, G. and Davis, R. 1980. Neurophysiological mechanisms in abnormal reflex activities in cerebral palsy and spinal spasticity. J. Neurol. Neurosurg. Psychiat. 43:333–342.
Fasano, V. A., Barolat-Romana, G., Zeme, S., and Sguazzi, L. 1979. Electrophysiological assessment of spinal circuits in spasticity by direct dorsal root stimulation. Neurosurgery, 4:146–151.
Lindsley, D. B., Schreiner, L. H., and Magoun, H. W. 1949. An electromyographic study of spasticity. J. Neurophysiol. 12:197–205.
Delwaide, P. J. 1985. Electrophysiological analysis of the mode of action of muscle relaxants in spasticity. Ann. Neurol. 17:90–95.
Dimitrijevic, M. M., Dimitrijevic, M. R., Sherwood, A. M., and Vanderlinden, C. 1989. Clinical neurophysiological techniques in the assessment of spasticity. Pages 64–83in Physical medicine and rehabilitation: State of the art reviews. Hanley & Belfus, Inc., Philadelphia.
Heller, A. H., and Hallett, M. 1982. Electrophysiological studies with the spastic mutant mouse. Brain Res. 234:299–308.
Meinck, H. M. 1976. Occurrence of the H reflex and the F wave in the rat. Electroencephalogr. Clin. Neurophysiol. 41:530–533.
Simpson, R. K. Jr., Robertson, C. S., and Goodman, J. C. 1989. Alterations in the corticomotor evoked potential following spinal cord ischemia. J Neurosci Meth, 28:171–178.
Simpson, R. K. Jr., Robertson, C. S., and Goodman, J. C. 1991. Segmental release of amino acid neurotransmitters from transcranial stimulation. Neurochem. Res. 16:89–94.
Simpson, R. K. Jr., Robertson, C. S., and Goodman, J. C. 1991. Release of segmental amino acid neurotransmitters in response to peripheral afferent and motor cortex stimulation: A pilot study. In Press, Life Sci (Pharm Lett), 49:113–118.
Simpson, R. K. Jr., Robertson, C. S., Goodman, J. C., and Halter, J. A. 1991. Recovery of amino acid neurotransmitters from the spinal cord during posterior epidural stimulation: A preliminary report. J. Am. Paraplegia Soc. 14:4–9.
Simpson, R. K. Jr., Robertson, C. S., and Goodman, J. C. 1993. Glycine: An important potential component of spinal shock. Neurochem. Res. 18:887–892.
Simpson, R. K. Jr., Robertson, C. S., and Goodman, J. C. 1993. Glycine: A potential mediator of electrically induced pain modification. Biomed. Lett. 48:193–207.
Simpson, R. K. Jr., Robertson, C. S., and Goodman, J. C. 1992. Segmental amino acid neurotransmitter recovery during posterior epidural stimulation after spinal cord injury. J. Am. Paraplegia Soc. 16:34–41.
Masland, R. 1985. Preface. Pages XV-XVI,in Eccles, J. and Dimitrijevic, M. R. (eds.), Recent Achievements in Restorative Neurology, Upper Motor Neuron Functions and Dysfunctions, Karger, Basel.
Park, T. S., Phillips, L. H., and Peakock, W. J. 1989. Preface. Pages xiii,in Park, T. S., Phillips, L. H., and Peakock, W. J., (eds.), Management of spasticity in cerebral palsly and spinal cord injury, Neurosurgery: State of the Art Review, Hanley & Belfus, Inc., Philadelphia.
Faganel, J. and Dimitrijevic, M. R. 1982. Study of propriospinal interneuron system in man. J Neurol Sci, 56:155–172.
Nathan, P. W. and Smith, M. C. 1959. Fasciculi proprii of the spinal cord in man. Review of present knowledge. Brain 82:610–668.
Neilson, P. D. 1972. Interaction between voluntary contraction and tonic stretch reflex transmission in normal and spastic patients. J. Neurol. Neurosurg. Psychiat. 35:853–860.
Shapovalov, A. I. 1975. Neuronal organization and synaptic mechanisms of supraspinal motor control in vertebrates. Rev. Physiol. Biochem. Pharmacol. 72:1–54.
Amassian, V. E., Stewart, B. S., Quirk, G. J., and Rosenthal, J. L. 1987. Physiological basis of motor effects of a transient stimulation to cerebral cortex, Neurosurgery 20:74–93.
Sherrington, C. S. and Sowton, S. C. M. 1915. Observations on reflex responses to single break shocks. J. Physiol. (London), 49:331–348.
Rizzoli, A. A. 1968. Distribution of glutamic acid, aspartic acid, g-aminobutyric acid and glycine in six areas of cat spinal cord before and after transection. Brain Res. 11:11–18.
Roberts, P. J., and Mitchell, J. F. 1972. The release of amino acids from the hemisected spinal cord during stimulation. J. Neurochem. 19:2473–2481.
Aprison, M. H. 1990. The discovery of the neurotransmitter role of glycine. Pages 1–23.in Ottersen, O. P. and Storm-Mathisen, J. (eds), Glycine Neurotransmission, John Wiley & Sons Ltd, New York.
Aprison, M. H., Shank, R. P., and Davidoff, R. A. 1969. A comparison of the concentration of glycine, a transmitter suspect, in different areas of the brain and spinal cord in seven different vertebrates. Comp. Biochem. Physiol. 28:1345–1355.
Christensen, H., Fykse, E. M., and Fonnum, F. 1990. Uptake of glycine into synaptic vesicles isolated from rat spinal cord. J. Neurochem. 54:1142–1147.
Kish, P. E., Fischer-Bovenkerk, C., and Ueda, T. 1989. Active transport of g-aminobutyric acid and glycine into synaptic vesicles. Proc. Natl. Acad. Sci. 86:3877–3881.
Berger, S. J., Carter, J. G., and Lowry, O. H. 1977. The distribution of glycine, GABA, glutamate, and aspartate in rabbit spinal cord, cerebellum and hippocampus. J. Neurochem. 28:149–158.
Fagg, G. E., Jordan, C. C., Webster, R. A. 1978. Descending fibre-mediated release of endogenous glutamate and glycine from the perfused cat spinal cord in vivo. Brain Res. 158:159–170.
Graham, L. T., Shank, R. P., Werman, R., and Aprison, M. H. 1967. Distribution of some synaptic transmitter suspects in cat spinal cord: glutamic acid, aspartic acid, g-aminobutyric acid, glycine, and glutamine. J. Neurochem. 14:465–472.
Ljungdahl, A., and Hokfelt, T. 1973. Accumulation of 3H-glycine in interneurons of the cat spinal cord. Histochemie, 33:277–280.
Davidoff, R. A. 1989. Mode of action of antispasticity drugs. Pages 315–324,in Park, T. S., Phillips, L. H., and Peakock, W. J., (eds.), Management of spasticity in cerebral palsly and spinal cord injury, Neurosurgery: State of the Art Review, Hanley & Belfus, Inc., Philadelphia.
Henneman, E. and Mendell, L. M. 1981. Functional organization of motorneuron pool and its inputs. Pages 423–507.in Brookhart, J. M. and Mountcastle, V. B., (eds.), The Nervous System, Handbook of Physiology, American Physiological Society, Bethesda.
Farrant, M., and Webster, R. A. 1989. Pages 161–219.in Boulton, A., Baker, G. B., and Juorio, A. V., (eds), Drugs as tools in neurotransmitter research. Humana Press Inc., Clifton.
Farrant, M., Gibbs, T. T., and Farb, D. H. 1990. Molecular and cellular mechanisms of GABA/Benzodiazepine-receptor regulation: Electrophysiological and biochemical studies. Neurochem. Res. 15:175–191.
Simpson, R. K. Jr., Robertson, C. S., and Goodman, J. C. 1990. Spinal cord ischemia-induced elevation of amino acids: Extracellular measurement with microdialysis. Neurochem. Res. 15:635–639.
Cahusac, P. M. B., Evans, R. H., Hill, R. G., Todriguez, R. E., and Smait, D. A. S. 1984. The behavioural effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology 23:719–724.
Gerber, G., Cerne, R., and Randic, M. 1991. Participation of excitatory amino acid receptors in the slow excitatory synaptic transmission in rat spinal dorsal horn. Brain Res. 561:236–251.
Hao, J. X., Xu, X. J., Aldskogius, H., Seiger, A., and Hallin Z. W. 1991. The excitatory amino acid receptor antagonist MK-801 prevents the hypersensitivity induced by spinal cord ischemia in the rat. Exp. Neurol. 113:182–191.
Turski, L., Schwarz, M., Turski, W. A., Klockgether, T., Sontag, K. H., and Collins, J. F. 1985. Muscle relaxant action of excitatory amino acid antagonists. Neurosci. Lett. 53:321–326.
Chizhmakov, I. V., Kiskin, N. I., Krishtal, O. A., and Tsyndrenko, A. Y. 1989. Glycine action on N-methy-D-aspartate receptors in rat hippocampal neurons. Neurosci. Lett. 99:131–136.
McNamara, D., and Dingledine, R. 1990. Dual effect of glycine on NMDA-induced neurotoxicity in rat cortical cultures. J. Neurosci. 10:3970–3976.
Patel, J., Zinkland, W. C., Thompson, C., Keith, R., and Salama, A. 1990. Role of glycine in the N-methyl-D-aspartate-mediated neuronal cytotoxicity. J. Neurochem. 54:849–854.
Lester, R. A. J., Tong, G., and Jahr, C. E. 1993. Interactions between the glycine and glutamate binding sites of the NMDA receptor. J. Neurosci. 13:1088–1096.
Lynch, D. R., Anegawa, N. J., Verdoorn, T., and Pritchett, D. B. 1993. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Molec Pharmacol, 45:540–545.
Van den Pol, A. N., and Gorcs, T. 1988. Glycine and glycine receptor immunoreactivity in brain and spinal cord. J Neurosci. 8:472–492.
Arizala, A. M., Rigamonti, D. D., Long, J. B., Kraimer, J. M., and Holaday, J. W. 1990. Effects of NMDA receptor antagonists following spinal ischemia in the rabbit. Exp. Neurol. 108:232–240.
Budai, D., Wilcox, G. L., and Larson, A. A. 1992. Enhancement of NMDA-evoked neuronal activity by glycine in the rat spinal cord in vivo. Neurosci. Lett. 135:265–268.
Douglas, J. R., Noga, B. R., Dai, X., and Jordan, L. M. 1993. The effects of intrathecal administration of excitatory amino acid agonists and antagonists on the initiation of locomotion in the adult cat. J. Neurosci., 13:990–1000.
Geyer, S. W., Gudden, W., Betz, H., Gnahn, H., and Weindl, A. 1987. Co-localization of choline acetyltransferase and postsynaptic glycine receptors in motoneurons of rat spinal cord demonstrated by immunocytochemistry: Neuroscience Lett. 82:11–15.
Bowker, R. M. and Abhold, R. H. 1990. Evoked changes in 5-hydroxytryptamine and norepinephrine release: in vivo dialysis of the rat dorsal horn. Eur. J. Pharmacol. 175:101–106.
Brodin, E., Linderoth, B., Gaselius, B., and Ungerstedt, U. 1987. In vivo release of substance P in cat dorsal horn studied with microdialysis. Neurosci. Lett. 76:357–362.
Pragg, H. V., and Frenk, H. 1990. The role of glutamate in opiate descending inhibition of nociceptive spinal reflexes. Brain Res. 524:101–105.
Schwarz, M., Klockgether, T., Wullner, U., Turski, L., and Sontag, K. H. 1988. d-aminovaleric acid antagonizes the pharmacological actions of baclofen in the central nervous system. Exp. Brain Res. 70:618–626.
Skilling, S. R., Harkness, D. H., and Larson, A. A. 1992. Experimental peripheral neuropathy decreases the dose of substance P required to increase excitatory amino acid release in the CSF of the rat spinal cord. Neurosci. Lett. 139:92–96.
Smullin, D. H., Skilling, S. R., and Larson, A. A. 1990. Interaction between substance P, calcitonin gene-related peptide, taurine and excitatory amino acids in the spinal cord. Pain 42:93–101.
Sorkin, L. S., Steinman, J. L., Hughes, M. G., Willis, W. D., and McAdoo, D. J. 1988. Microdialysis recovery of serotonin released in the spinal cord dorsal horn. J Neurosci Meth, 23:131–138.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simpson, R.K., Gondo, M., Robertson, C.S. et al. The influence of glycine and related compounds on spinal cord injury-induced spasticity. Neurochem Res 20, 1203–1210 (1995). https://doi.org/10.1007/BF00995384
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00995384